[b]Therapeutic treatment of malaria continues to flourish[/b]

Malaria is regarded as one of the most dangerous parasitic infections and remains a major cause of morbidity and death. The research for treatment of malaria has thus changed and seen a significant growth, more so over the last two decades during which time the death tolls of the disease had been noted as the highest.

This report: Malaria - Pipeline Review, H1 2014, shares comprehensive information and latest developments on the developments in therapeutic treatments for Malaria. Research indicates that the market for therapeutic drugs consists of the 2.8 billion people living in malaria endemic areas alongwith another 20-30 million people, mainly Europeans and North Americans, who travel or live in malaria prone areas.

Some of the largest markets include China, India, and Indonesia with a total of 1.9 billion people exposed; Latin America, with 119 million; and sub-Saharan Africa with 400 million. An estimated 200 million clinical cases occur each year, with around 2 million deaths annually, primarily among African children.


[b]Market outlook[/b]

At present, the therapeutic market for malaria is dominated by chloroquine by virtue of its safety, extensive availability and low price. Approximately 20% of the total production of this drug is distributed through national control programmes and 80% through other channels; chloroquine is probably the second or third most widely consumed drug in the world as a treatment for this recurring disease. While secondary drugs containing sulfadoxine/pyrimethamine are also available in the markets, chloroquine remains the dominant player. The global market for antimalarial drugs is likely to be of the order of USD 100-120 million, with chloroquine making up about USD 64-80, sulfadoxine/pyrimethamine about USD 20 million, and other drugs making up USD 10-20 million.


[b]For further insights,[/b]

Visit: http://www.researchonglobalmarkets.com/malaria-pipeline-review-h1-2014.html


[b]About Research on Global Markets[/b]

Research on Global Markets is a leading source for market research on various sectors globally, offering premium research content from worldwide publishers of market research reports. Our database hosts premium market research content developed by global publishers. It offers premium industry research reports, company profiles and country briefs. We have a dedicated team of research professionals who can facilitate, in an unbiased manner, the process of identifying appropriate market research reports that are targeted to fulfil all your information-related requirements.


[b]For more details on the content of each report and ordering information please contact:[/b]

Email: [email protected]
US: +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE: Researchonglobalmarkets.com
Blog: blog.researchonglobalmarkets.com